GLP-1 medications can also cause tiredness, especially when treatment starts or doses increase, because of reduced calorie intake, dehydration, gastrointestinal side effects, and changes in glucose levels
This personalized approach mitigates risks and optimizes outcomes
This initial phase typically lasts for four weeks, proceeding cautiously to ensure the medication is well-tolerated while beginning to impact appetite control and blood sugar levels positively
It is also worth noting that our comparison with topiramate, which shares a weight loss property, may partly reflect topiramates poor real-world tolerability and compliance rather than a true pharmacological advantage of GLP1 RAs. However, he also stated that the overall signal is encouraging and justifies further investigation
However, dedicated analyses examining whether women experience different rates of adverse events, different magnitudes of weight loss, or distinct metabolic responses compared to men have not yet been published in peer-reviewed literature
Post-injection care: Do not rub or massage the injection site after administration, as this may increase irritation or alter medication absorption